5 years and $80 million later our Nation's gulf war veterans still do not have the answer to their most pressing question. What caused Persian Gulf war syndrome? For nearly a year, my office has been working with Dr. James Moss, a researcher in my district who may have found an explanation. Dr. Moss found that when common pesticides--for example, Deet--were combined with drugs used by our soldiers to limit the effects of biological and chemical weapons, Deet became seven times as toxic as when used alone. Congress needs to support continued research based on Dr. Moss' studies. To that end, I have asked the chairman of the Appropriations Committee to earmark $3 million to simply continue this research at a civilian research facility. While this session is quickly ending, the needs of our servicemen are not based on Congress's fiscal year. Unfortunately, our Nation's troops may be needed again in a region where chemical warfare is a possibility. When they put their lives on the line to protect our freedoms, we should hold nothing back to ensure their safety. We owe our veterans, present and future, this investment.
Karen Thurman: “5 years and $80 million later our Nation's gulf war veterans still do not have the answer to their most pressing…”
Editor's note · Context
Addressing the need for research on Gulf War syndrome and funding for veterans' health.
Share
More from Karen Thurman
one other issue that the gentlewoman from Florida (Ms. Brown) brought up that I also think is very important in this debate and quite frankly it is an issue that our Republican colleagues are having, I can say from CongressDaily today, one…
I rise today to talk about Social Security and the President's budget. As we all know, the budget resolution is going to come to the House today, and I think it is very important that we highlight what the budget will do to Social…
the only thing I would say then is maybe us being here tonight and talking about this issue, maybe it will give some pause; and maybe we will have the opportunity to have that debate.
Yes. And we also correct a somewhat curious operation where they have actually kind of been involved or engaged with some generic companies where they actually have bought out or have actually delayed the generic drug coming to the market…





